📣 Introducing Tracenable Pro: Unlock Unlimited Data Exports & Disclosures Access.

Nuvalent Inc

Common Name
Nuvalent
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
218
Ticker
NUVL
Exchange
NASDAQ/NGS
Description
Nuvalent Inc. is a biopharmaceutical company dedicated to the innovative development of small molecule therapies for cancer treatment. The company's primary focus is on creating targeted solutions for...

Nuvalent's Financial Statements Preview

Below are the financial statements of Nuvalent, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in thousands of USD
2024 as of 2024-12-31
2023 as of 2023-12-31
Assets
Current assets
Cash and cash equivalents
145,691a
335,387a
Marketable securities
972,611a
384,518a
Prepaid expenses and other current assets
14,146a
6,583a
Total current assets
1,132,448a
726,488a
Other assets
9,304a
5,896a
Total assets
1,141,752a
732,384a
Liabilities and stockholders’ equity
Current liabilities
Accounts payable
5,225a
9,274a
Accrued expenses
48,795a
22,549a
Total current liabilities
54,020a
31,823a
Related party revenue share liability
17,940a
0a
Total liabilities
71,960a
31,823a
Stockholders’ equity
Preferred stock
0a
0a
Class A common stock
7a
6a
Class B convertible common stock
1a
1a
Additional paid-in capital
1,616,895a
986,819a
Accumulated other comprehensive income (loss)
-59a
31a
Accumulated deficit
-547,052a
-286,296a
Total stockholders’ equity
1,069,792a
700,561a
Total liabilities and stockholders’ equity
1,141,752a
732,384a
Download Data

Verified Sources Behind Nuvalent’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Nuvalent’s data sources below and access millions more through our Disclosure Search.

a. Nuvalent's 10-K 2024
a. Nuvalent's 10-K 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?